Cargando…

Deregulation of VEGFR-2 and PDGFR Expression and Microvascular Density in a Triple-Negative Model of Canine Malignant Mammary Tumors with Lymph Node or Lung Metastasis

Canine mammary tumors (CMT) represent the most common cancer in noncastrated female dogs. Interestingly, triple-negative tumors are the most common molecular subtype in female dogs. In this study, we proposed to evaluate the expression of vascular endothelial growth factor receptor 2 (VEGFR-2), Plat...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Anjos, Denner Santos, Vital, Aline Fernandes, Lainetti, Patrícia de Faria, Leis-Filho, Antonio Fernando, Dalmolin, Fabiola, Elias, Fabiana, Calazans, Sabryna Gouveia, Fonseca-Alves, Carlos Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466043/ https://www.ncbi.nlm.nih.gov/pubmed/30634402 http://dx.doi.org/10.3390/vetsci6010003

Ejemplares similares

Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro
por: Leis-Filho, Antonio Fernando, et al.
Publicado: (2021)

Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro
por: Lainetti, Patrícia F., et al.
Publicado: (2021)

Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo
por: de Faria Lainetti, Patrícia, et al.
Publicado: (2020)

Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinoma
por: Dos Anjos, Denner S., et al.
Publicado: (2019)

Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway
por: Kobayashi, Priscila E., et al.
Publicado: (2020)

Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma
por: Setyo, Laura C., et al.
Publicado: (2023)

Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors
por: Prado, Maria Carolina Mangini, et al.
Publicado: (2019)

Prevalence of Glomerulopathies in Canine Mammary Carcinoma
por: Crivellenti, Leandro Z., et al.
Publicado: (2016)

Firocoxib as a Potential Neoadjuvant Treatment in Canine Patients with Triple-Negative Mammary Gland Tumors
por: Brandi, Andressa, et al.
Publicado: (2022)

Effect of VEGFR, PDGFR and PI3K/mTOR Targeting in Glioblastoma
por: PURCARU, S.O., et al.
Publicado: (2015)

E-Cadherin Downregulation is Mediated by Promoter Methylation in Canine Prostate Cancer
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2019)

Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma
por: Chu, Jie Sheng, et al.
Publicado: (2013)

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome
por: Estevez-Garcia, Purificacion, et al.
Publicado: (2012)

Squamous cell carcinoma of unknown primary origin in a dog presenting with bone metastasis
por: SIERRA MATIZ, Oscar Rodrigo, et al.
Publicado: (2019)

A Comparative in Silico Analysis of CD24’s Prognostic Value in Human and Canine Prostate Cancer
por: Leis-Filho, Antonio Fernando, et al.
Publicado: (2021)

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
por: Pierotti, Catia L., et al.
Publicado: (2023)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets
por: Zong, Yao, et al.
Publicado: (2016)

PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
por: Bai, Feng, et al.
Publicado: (2021)

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
por: Friedman, Adam A., et al.
Publicado: (2015)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor
por: Michael, M, et al.
Publicado: (2010)

VEGFR2(+)PDGFRβ(+) circulating precursor cells participate in capillary restoration after hyperoxia acute lung injury (HALI)
por: Jones, Rosemary, et al.
Publicado: (2009)

Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
por: Avril, Stefanie, et al.
Publicado: (2017)

Thymidine Phosphorylase Expression and Microvascular Density Correlation Analysis in Canine Mammary Tumor: Possible Prognostic Factor in Breast Cancer
por: Zizzo, Nicola, et al.
Publicado: (2019)

Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas
por: Sakalauskaitė, Simona, et al.
Publicado: (2022)

Rapid clearance of epigenetic protein reporters from wound edge cells in Drosophila larvae does not depend on the JNK or PDGFR/VEGFR signaling pathways
por: Anderson, Aimee E., et al.
Publicado: (2014)

Immunohistochemical localization of VEGFR-2 in mouse mammary gland during reproductive cycle
por: Islam, Mohammad Saiful, et al.
Publicado: (2021)

Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
por: Lainetti, Patrícia de Faria, et al.
Publicado: (2020)

Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth
por: Hammer, Anisha M., et al.
Publicado: (2017)

PDGFRα(+) stromal adipocyte progenitors transition into epithelial cells during lobulo-alveologenesis in the murine mammary gland
por: Joshi, Purna A., et al.
Publicado: (2019)

Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors
por: Callahan, Robert, et al.
Publicado: (2012)

Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues
por: Kochan, David Z., et al.
Publicado: (2015)

Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells
por: Wu, Erxi, et al.
Publicado: (2008)

AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR
por: Zhou, Yuanfeng, et al.
Publicado: (2012)

Structural optimization and evaluation of novel 2-pyrrolidone-fused (2-oxoindolin-3-ylidene)methylpyrrole derivatives as potential VEGFR-2/PDGFRβ inhibitors
por: Yang, Ting-Hsuan, et al.
Publicado: (2017)

Comparative mammary oncology: canine model
por: Cassali, Geovanni Dantas
Publicado: (2013)

Current biomarkers of canine mammary tumors
por: Kaszak, Ilona, et al.
Publicado: (2018)

Epigenetic alterations in canine mammary cancer
por: Borges, Bárbara do Nascimento
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sfjat9llm8vehe5ieo7njh6fp9